Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Beijing, China9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach | Hepatoid Adenocarcinoma of Stomach | Recruiting | Phase 2 | 2026-09-22 | NCT06992362 | |
| Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Not stated | 2026-08-04 | NCT07745322 | |
| Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Phase 2 | 2026-01-22 | NCT07357532 | |
| Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach | Hepatoid Adenocarcinoma of Stomach | Recruiting | Phase 2 | 2025-12-02 | NCT07178340 | |
| Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor Cancer | Recruiting | Phase 1 | 2025-08-24 | NCT07139067 | |
| Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-02-27 | NCT06849167 | |
| A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric and Gastroesophageal Junction Adenocarcinoma | Recruiting | Phase 3 | 2024-06-24 | NCT06341335 | |
| AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not stated | 2023-09-28 | NCT06035250 | |
| Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not stated | 2023-02-14 | NCT05722275 |